Cepheid (CPHD) PT Cut to $39 at Leerink Partners

Leerink Partners analyst Dan Leonard reiterated a Market Perform rating and lowered his price target on Cepheid (NASDAQ: CPHD) to $39.00 (from $44.00) following third quarter results.

Leonard commented, "We are lowering our EPS estimates following the release of CPHD’s full Q3 operating results, which included additional detail on Q4 guidance and a flat outlook for 2016 gross margins (GM). We now have a higher degree of comfort with the company’s Q4 revenue guidance following a more in-depth look at the underlying drivers. We are maintaining our Market Perform rating but reducing our price target to $39."

For an analyst ratings summary and ratings history on Cepheid click here. For more ratings news on Cepheid click here.

Shares of Cepheid closed at $32.25 yesterday.

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• Tata Motors Passenger Vehicles (TMPV:IN) PT Raised to INR375 at ICICI Securities
• New Street Research Upgrades Micron Technology (MU) to Buy